Stay updated on Pediatric Emicizumab SC in Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Pediatric Emicizumab SC in Hemophilia A Clinical Trial page.

Latest updates to the Pediatric Emicizumab SC in Hemophilia A Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe record provides details of the completed pediatric emicizumab study for hemophilia A, including eligibility, treatment cohorts, locations, outcomes, and study documents.SummaryDifference96%

- Check14 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check21 days agoChange DetectedA banner announces NIH website transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check28 days agoChange DetectedThe site footer revision label changes from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page, while the study record remains unavailable.SummaryDifference0.2%

- Check56 days agoChange Detected403 Forbidden page now appears for the study, replacing the prior study record content and links to documents. The study description and related documents have been removed, leaving only the header and footer with the error message.SummaryDifference22%

Stay in the know with updates to Pediatric Emicizumab SC in Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Emicizumab SC in Hemophilia A Clinical Trial page.